Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial

Primary Prevention ◽

High Intensity ◽

Low Dose ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients with Type 2 Diabetes: A Randomized Controlled Trial

Journal of Vascular Surgery ◽

10.1016/j.jvs.2009.03.020 ◽

2009 ◽

Vol 49 (5) ◽

pp. 1357-1358

Author(s):

H. Ogawa ◽

M. Nakayama ◽

T. Morimoto

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

JAMA ◽

10.1001/jama.2008.623 ◽

2008 ◽

Vol 300 (18) ◽

pp. 2134 ◽

Cited By ~ 534

Author(s):

Hisao Ogawa

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Incorrect Data in Text and Table in: Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial

JAMA ◽

10.1001/jama.301.18.1882 ◽

2009 ◽

Vol 301 (18) ◽

pp. 1882 ◽

Cited By ~ 1

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Low Dose Aspirin ◽

Incorrect Data

Faculty Opinions recommendation of Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1144941.602044 ◽

2009 ◽

Author(s):

Timothy Lyons ◽

Madona Azar

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Yearbook of Vascular Surgery ◽

10.1016/s0749-4041(09)79136-5 ◽

2009 ◽

Vol 2009 ◽

pp. 6-7

Author(s):

G.L. Moneta

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Data Error in Table in: Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial

JAMA ◽

10.1001/jama.2012.14657 ◽

2012 ◽

Vol 308 (18) ◽

pp. 1861

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Dose Aspirin ◽

Low Dose Aspirin ◽

Data Error

110-LB: The Korean Titration: A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 Units/ml in Patients with Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db20-110-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 110-LB

Author(s):

JAE HYUN BAE ◽

CHANG HO AHN ◽

YE SEUL YANG ◽

SUN JOON MOON ◽

SOO HEON KWAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

Diabetes ◽

10.2337/db20-88-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 88-LB

Author(s):

JULIO ROSENSTOCK ◽

AMAR ALI ◽

JURIS J. MEIER ◽

FRANCESCO GIORGINO ◽

CRISTIAN GUJA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Controlled Trial ◽

Similar Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Real World Setting ◽

Sodium Glucose Cotransporter

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Diabetes Care ◽

10.2337/dc13-2759 ◽

2014 ◽

Vol 37 (8) ◽

pp. 2168-2176 ◽

Cited By ~ 166

Author(s):

Guillermo Umpierrez ◽

Santiago Tofé Povedano ◽

Federico Pérez Manghi ◽

Linda Shurzinske ◽

Valeria Pechtner

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Effect of low-dose spironolactone on resistant hypertension in type 2 diabetes mellitus: a randomized controlled trial in a sub-Saharan African population

BMC Research Notes ◽

10.1186/s13104-016-1987-5 ◽

2016 ◽

Vol 9 (1) ◽

Cited By ~ 10

Author(s):

Romance Nguetse Djoumessi ◽

Jean Jacques N. Noubiap ◽

Francois Folefack Kaze ◽

Mickael Essouma ◽

Alain Patrick Menanga ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Resistant Hypertension ◽

Low Dose ◽

Controlled Trial ◽

Randomized Controlled ◽

Sub Saharan